1
2
3
4
5
6
Geurten, Rose J., Struijs, Jeroen N., Elissen, Arianne M. J., Bilo, Henk J. G., van Tilburg, Chantal, Ruwaard, Dirk
Veröffentlicht in: Geurten , R J , Struijs , J N , Elissen , A M J , Bilo , H J G , van Tilburg , C & Ruwaard , D 2022 , ' Delineating the Type 2 Diabetes Population in the Netherlands Using an All-Payer Claims Database : Specialist Care, Medication Utilization and Expenditures 2016-2018 ' , PharmacoEconomics - open , vol. 6 , no. 2 , pp. 219-229 . https://doi.org/10.1007/s41669-021-00308-0;
2022
Veröffentlicht in: Geurten , R J , Struijs , J N , Elissen , A M J , Bilo , H J G , van Tilburg , C & Ruwaard , D 2022 , ' Delineating the Type 2 Diabetes Population in the Netherlands Using an All-Payer Claims Database : Specialist Care, Medication Utilization and Expenditures 2016-2018 ' , PharmacoEconomics - open , vol. 6 , no. 2 , pp. 219-229 . https://doi.org/10.1007/s41669-021-00308-0;
2022
7
Geurten, Rose J., Elissen, Arianne M.J., Bilo, Henk J.G., Struijs, Jeroen N., Van Tilburg, Chantal, Ruwaard, Dirk
Veröffentlicht in: Geurten , R J , Elissen , A M J , Bilo , H J G , Struijs , J N , Van Tilburg , C & Ruwaard , D 2021 , ' Identifying and delineating the type 2 diabetes population in the Netherlands using an all-payer claims database : Characteristics, healthcare utilisation and expenditures ' , BMJ Open , vol. 11 , no. 12 , e049487 . https://doi.org/10.1136/bmjopen-2021-049487;
2021
Veröffentlicht in: Geurten , R J , Elissen , A M J , Bilo , H J G , Struijs , J N , Van Tilburg , C & Ruwaard , D 2021 , ' Identifying and delineating the type 2 diabetes population in the Netherlands using an all-payer claims database : Characteristics, healthcare utilisation and expenditures ' , BMJ Open , vol. 11 , no. 12 , e049487 . https://doi.org/10.1136/bmjopen-2021-049487;
2021
8
9
10